John F. Conway and Yolanda Sanchez of 20/15 Visioneers discuss why a FAIR multi-omics scientific data and process environment must be valued and guarded as one of an organization’s top assets.
The current complexity of multi-omics in the pharmaceutical, biotech, agriscience, and consumer goods companies is extensive and many partner-vendors and services organizations are ill-equipped to handle it. If you are not under a higher than normal sense of urgency to build out your next-generation Life Science Data environment, you may want to start asking your organization some questions.
In this white paper the authors write about:
- Why your organization needs a data strategy in place now
- Common challenges in mult-Life Science Data management and integration
- How Genestack's Genestack ODM helped a top-5 pharma revamp their Life Science Data environment
Genestack ODM standardizes, integrates, and indexes Life Science Data and metadata into analysis-ready data accessible for integration with external data catalogs/visualization tools, via Genestack’s data catalog, or for tailored data portals.